Masayuki Hayashi

Comparison of the Mucosal Adjuvant Endocine™ with Two Well-Known Adjuvants: Cholera Toxin and Alum

J. Hinkula, T. Falkeborn, Anna-Karin Maltais, 2015 .

RNA is an Adjuvanticity Mediator for the Lipid-Based Mucosal Adjuvant, Endocine

C. Coban, K. Ishii, T. Aoshi, 2016, Scientific Reports.

Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1α Release to Promote Inducible Bronchus-Associated Lymphoid Tissue Formation.

C. Coban, K. Ishii, S. Ziegler, 2016, Immunity.

Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells

C. Coban, K. Ishii, T. Aoshi, 2016, Oncotarget.

Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant.

K. Ishii, T. Aoshi, K. Kobiyama, 2016, Vaccine.

Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist

C. Coban, K. Ishii, S. Akira, 2014, Proceedings of the National Academy of Sciences.

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines

H. Yamada, C. Coban, K. Ishii, 2016, EBioMedicine.